The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Pertuzumab plus trastuzumab (P+T) in patients (pts) with biliary tract cancer (BTC) with ERBB2/3 amplification (amp), overexpression (oe), or mutation (mut): Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) study.
 
Timothy Lewis Cannon
Honoraria - AstraZeneca; Bayer; Deciphera
Consulting or Advisory Role - Navican
Other Relationship - Navican/ Intermountain Healthcare
 
Michael Rothe
No Relationships to Disclose
 
Elizabeth Garrett-Mayer
No Relationships to Disclose
 
Vi Kien Chiu
Research Funding - Alkermes (Inst); Arcus Biosciences (Inst); BioNTech SE (Inst); Incyte (Inst); Intra-Immusg (Inst); Leap Therapeutics (Inst); NGM Biopharmaceuticals (Inst); Seattle Genetics/Astellas (Inst); TyrNovo (Inst)
 
Jimmy J. Hwang
Consulting or Advisory Role - Bristol-Myers Squibb; Caris Centers of Excellence; Deciphera; Incyte; Pfizer; QED Therapeutics
Speakers' Bureau - Bristol-Myers Squibb; Deciphera; Incyte
Research Funding - Boehringer Ingelheim (Inst); Caris Centers of Excellence (Inst)
 
Namrata Vijayvergia
Honoraria - Guidepoint Global
Consulting or Advisory Role - AstraZeneca/Daiichi Sankyo; Ipsen; Isotopen Technologien; Novartis; Taiho Oncology; Tersera
Research Funding - Puma Biotechnology (Inst); Zymeworks (Inst)
 
Olatunji B. Alese
Consulting or Advisory Role - Bristol-Myers Squibb; Pfizer; QED Therapeutics; Seagen; Taiho Oncology
Research Funding - Bristol-Myers Squibb (Inst); Calithera Biosciences (Inst); Corcept Therapeutics (Inst); GlaxoSmithKline (Inst); Hutchison MediPharma (Inst); Ipsen (Inst); MabSpace Biosciences (Inst); PCI Biotech (Inst); SynCoreBio (Inst); Taiho Pharmaceutical (Inst)
 
Elie G. Dib
Other Relationship - Genentech (Inst); Merck (Inst)
 
Herbert Leon Duvivier
Speakers' Bureau - AstraZeneca; Guardant Health; Regeneron
 
Kelsey Klute
Consulting or Advisory Role - Cancer Expert Now; Daiichi Sankyo/Lilly; Pfizer
Research Funding - AstraZeneca (Inst); FibroGen (Inst)
 
Vaibhav Sahai
Consulting or Advisory Role - AstraZeneca; Celgene; GlaxoSmithKline; Halozyme; Histosonics; Incyte; Ipsen; Klus Pharma; Newlink Genetics; QED Therapeutics; Rafael Pharmaceuticals
Research Funding - Actuate Therapeutics (Inst); Agios (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Celgene (Inst); Clovis Oncology (Inst); Debiopharm Group (Inst); Exelixis (Inst); FibroGen (Inst); Halozyme (Inst); Incyte (Inst); Ipsen (Inst); MedImmune (Inst); Pancreatic Cancer Action Network (Inst); Rafael Pharmaceuticals (Inst); Relay Therapeutics (Inst); Syros Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - ASCO; FibroGen; FibroGen
 
Eugene R Ahn
Employment - Cancer Treament Centers of America
Leadership - Cancer Treament Centers of America
 
Deepti Behl
Consulting or Advisory Role - AAA HealthCare; AstraZeneca; Bristol Myers Squibb Foundation; Ipsen; Janssen Oncology; Lilly; Mirati Therapeutics; Novartis; Signatera
Speakers' Bureau - AstraZeneca; Janssen Oncology
 
Sarah Sinclair
No Relationships to Disclose
 
Ramya Thota
No Relationships to Disclose
 
Walter John Urba
Consulting or Advisory Role - AstraZeneca/MedImmune; AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst)
Research Funding - Bristol-Myers Squibb (Inst); Galectin Therapeutics (Inst); MedImmune (Inst); Merck (Inst)
Patents, Royalties, Other Intellectual Property - Galectin Therapeutics (Inst); MedImmune (Inst)
 
Eddy Shih-Hsin Yang
Consulting or Advisory Role - AstraZeneca; Bayer; Clovis Oncology; Lilly; Strata Oncology
Research Funding - Clovis Oncology (Inst); Lilly (Inst); Novartis (Inst); Puma Biotechnology (Inst)
 
Gina N. Grantham
No Relationships to Disclose
 
Susan Halabi
Employment - ASCO
Honoraria - AVEO; Bristol-Myers Squibb; Sanofi
 
Richard L. Schilsky
Leadership - Clarified Precision Medicine; Leap Therapeutics
Stock and Other Ownership Interests - EQRx
Consulting or Advisory Role - Bryologyx; Cellworks; EQRx; Illumina; Scandion Oncology; Syapse; Zephyr AI
Research Funding - AstraZeneca (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Lilly (Inst); Merck (Inst); Pfizer (Inst); Seagen (Inst)